MeasuredReferenceDasatinib targets ABL2_ARG, BLK, EPHA3. Strongest hallmark effect: tumor promoting inflammation.
Top hallmarks
- tumor promoting inflammation5.6k
- evading apoptosis4.5k
- proliferation4.2k
Top pathways disrupted
- apical junction11.6k
- allograft rejection10.9k
- pi3k akt mtor signaling10.7k
Resistance landscape — Dasatinib
MeasuredReference1 known oncogenic variants exist on Dasatinib's top targets — see detail for inhibition impact.